Literature DB >> 2830070

Activation of liver macrophages in murine malaria is enhanced by vaccination.

J Taverne1, D Rahman, H M Dockrell, A Alavi, C Leveton, J H Playfair.   

Abstract

During blood-stage infection of mice with a lethal variant of Plasmodium yoelii, cells in both spleen and liver became activated to reach a peak at day 5. In mice protected by vaccination, activation was accelerated after infection. The most striking difference observed was in the 10-fold greater yield of infiltrating cells, including macrophages, obtained from the liver just before the mice recovered. Their capacity to give an oxidative burst and their cytotoxic activity against tumour cells was also more than 10 times normal. This suggests that the recruitment of inflammatory cells to the liver plays an important role in the protection of vaccinated mice against malaria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2830070      PMCID: PMC1542187     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.

Authors:  J H Playfair; J B De Souza; B J Cottrell
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

2.  Changes in oxidative burst capacity during murine malaria and the effect of vaccination.

Authors:  H M Dockrell; A Alavi; J H Playfair
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

3.  Lymphocyte traffic and lymphocyte destruction in murine malaria.

Authors:  J H Playfair; J B de Souza
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

4.  Role of macrophages in malaria: O2 metabolite production and phagocytosis by splenic macrophages during lethal Plasmodium berghei and self-limiting Plasmodium yoelii infection in mice.

Authors:  V Brinkmann; S H Kaufmann; M M Simon; H Fischer
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

5.  Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria.

Authors:  I A Clark; N H Hunt
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Oxidative killing of the intraerythrocytic malaria parasite Plasmodium yoelii by activated macrophages.

Authors:  C F Ockenhouse; H L Shear
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

7.  Expression of the natural resistance gene Lsh in resident liver macrophages.

Authors:  P R Crocker; J M Blackwell; D J Bradley
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst.

Authors:  H M Dockrell; J H Playfair
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  The role of the liver in immunity to blood-stage murine malaria.

Authors:  H M Dockrell; J B de Souza; J H Playfair
Journal:  Immunology       Date:  1980-10       Impact factor: 7.397

10.  Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.

Authors:  R R Freeman; A A Holder
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

View more
  4 in total

1.  Hepatic miRNA expression reprogrammed by Plasmodium chabaudi malaria.

Authors:  Denis Delić; Mohamed Dkhil; Saleh Al-Quraishy; Frank Wunderlich
Journal:  Parasitol Res       Date:  2010-11-18       Impact factor: 2.289

2.  A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice.

Authors:  P Jacobs; D Radzioch; M M Stevenson
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

3.  Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF.

Authors:  C A Bate; J Taverne; A Davé; J H Playfair
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

4.  Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo.

Authors:  C A Bate; J Taverne; J H Playfair
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.